Jun Hayashi

Jun Hayashi

Auto-generated profile, based on publicly available information

Jun Hayashi

Department of Cardiovascular Surgery, Saitama Medical University, International Medical Center, 1397-1 Yamane Hidaka, Saitama, 350-1298, Japan

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2020 in General Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
PDF file
JHJun Hayashi
Jun Hayashi
TUTetsuro Uchida
Tetsuro Uchida
SRSho Ri
Sho Ri
AHAzumi Hamasaki
Azumi Hamasaki
YKYoshinori Kuroda
Yoshinori Kuroda
MSMitsuaki Sadahiro
Mitsuaki Sadahiro

16 January 2003 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
XDXiaoming Du
Xiaoming Du
NSNing‐Yi Sun
Ning‐Yi Sun
JHJun Hayashi
Jun Hayashi
YCYang Chen
Yang Chen
MSMinoru Sugiura
Minoru Sugiura
YSYukihiro Shoyama
Yukihiro Shoyama

18 February 2022 in Interactive CardioVascular and Thoracic Surgery
Verified
Journal Article
Open access
PDF file
CTChiho Tokunaga
Chiho Tokunaga
YKYu Kumagai
Yu Kumagai
FCFumiya Chubachi
Fumiya Chubachi
YHYuto Hori
Yuto Hori
ATAkitoshi Takazawa
Akitoshi Takazawa
AYAkihiro Yoshitake
Akihiro Yoshitake
OBJECTIVES: Total arch replacement (TAR) using an endovascular approach has been initially introduced as the frozen elephant trunk technique (FET). In our institute, TAR using the FET with Frozenix has been used as the first-line treatment for distal aortic arch aneurysms since 2014. This study aimed to evaluate the early and long-term outcomes and demonstrate the efficacy of this procedure. METHODS: Between 2014 and 2021, 121 consecutive patients were treated with TAR using the FET with Frozenix for distal aortic arch aneurysms. Early and long-term outcomes were retrospectively analysed. RESULTS: The 30-day mortality rate was 2.5% (3/121). Of postoperative complications, paraplegia due to spinal cord injury occurred in 2 (1.7%) patients, stroke in 12 (9.9%) and acute renal failure in 10 (8.3%). At follow-up, 23 secondary aortic interventions were required and 8 (6.6%) patients underwent intended secondary thoracic endovascular aortic repair for residual descending aortic aneurysm. Late and aortic-related deaths occurred in 16 (13.2%) and 4 (3.3%) patients, respectively. The overall long-term survival rates at 1, 3 and 5 years were 87.6%, 83.1% and 65.4%, respectively, while the rates of freedom from aortic-related death at 1, 3 and 5 years were 95.7%, 95.7% and 84.8%, respectively. CONCLUSIONS: TAR using the FET with Frozenix for distal aortic arch aneurysms has acceptable early mortality and morbidity. Spinal cord injury and paraplegia occur less frequently than previously reported. The technique has satisfactory long-term survival and freedom from aortic-related death.

1 November 1990 in Cellular Immunology
Verified
Journal Article
Closed access
LSLe Sun
Le Sun
APArthur S. Piltch
Arthur S. Piltch
PLPingsheng Liu
Pingsheng Liu
LJLisa A. Johnson
Lisa A. Johnson
JHJun Hayashi
Jun Hayashi

25 June 2022 in JTCVS Open
Verified
Journal Article
Open access
JHJun Hayashi
Jun Hayashi
HNHiroyuki Nakajima
Hiroyuki Nakajima
TAToshihisa Asakura
Toshihisa Asakura
RSRi Sho
Ri Sho
CTChiho Tokunaga
Chiho Tokunaga
AYAkihiro Yoshitake
Akihiro Yoshitake
We aimed to determine the efficacy of total arch replacement with stented elephant trunk by comparing it with hemiarch replacement with and without open stent graft for acute aortic dissection type 1. We reviewed records of 177 patients who underwent hemiarch replacement (HAR group) (concomitant open stent, 125) and 98 patients who underwent total arch replacement (TAR group) (concomitant stented elephant trunk, 91) for acute type 1 dissection. Compared with the TAR group, the HAR group was older (68.1 vs 60.9 years; P < .01) and had more thrombosed false lumen (28.8% vs 4.1%, P < .01). In-hospital death occurred for 7 patients in the HAR group and 1 patient in the TAR group (P = .17). More patients in the TAR group had a postoperative thrombosed false lumen, compared with the HAR group (68% vs 54%, P = .03). In patients with preoperative nonthrombosed false lumen in the HAR group, the rate of postoperative thrombosis was significantly lower than with versus without an open stent (31% vs 65%, P = .01). The rate of freedom from an aortic arch event in the TAR group at 5 years was significantly greater than that in the HAR group (100% vs 83.7%, P = .01). Stented elephant trunk with TAR provided a high rate of false lumen thrombosis and a low incidence of arch events, whereas an open stent during HAR was not beneficial in terms of false lumen thrombosis and arch event prevention.

4 September 2024 in General Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
PDF file
JHJun Hayashi
Jun Hayashi
SNShingo Nakai
Shingo Nakai
KKKimihiro Kobayashi
Kimihiro Kobayashi
YKYoshinori Kuroda
Yoshinori Kuroda
EOEiichi Ohba
Eiichi Ohba
TUTetsuro Uchida
Tetsuro Uchida